Nanogen, Affymetrix, Definiens, Ontario Government, Lakehead University, Gentana, Monsanto, Li-Cor Biosciences, Biolog | GenomeWeb

Nanogen Shares Spike Up on European Patent News

Shares in Nanogen closed up Monday 22.28 percent, or $.88, in heavy-volume trade after the company said its SynX subsidiary had won a European patent.

The stock closed at $4.83 on the Nasdaq exchange as almost 6 million shares traded hands — compared to the average share volume of 636,863 for the past three months. The shares receded somewhat on Tuesday afternoon, falling 7.5 percent, or $.36, to $4.47.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.